News

Articles

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
 
Click below to access the full chapter.
Back

Last related news

August 17, 2021

Privacy in Brazil 2021

The Q&A guide gives a high-level overview of privacy rules and principles, including what national laws regulate the right to respect for Privacy in Brazil 2021

Ler notícia

July 5, 2021

Personalised medicine in Brazil: IP and regulatory challenges

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first Personalised medicine in Brazil: IP and regulatory challenges

Ler notícia

May 18, 2021

Anti-counterfeiting and Online Brand Enforcement: A Global Guide 2021

The growth of the Brazilian market and economy is paralleled by the increase in counterfeiting activities. The enforcement of IP rights involves Anti-counterfeiting and Online Brand Enforcement: A Global Guide 2021

Ler notícia